COVID-19 and clinical pharmacologyDownload in PDF
The article provides an overview of the role of clinical pharmacology in the management of the COVID-19 pandemic, including various strategies and horizons for studying the infection and analysis of the individual groups of drugs from the mechanism of action on the coronavirus to the effects they cause, the current clinical trials in COVID-19, the main trends, problems and challenges facing clinical pharmacology. The experience of using various drugs in real clinical practice and the role of clinical recommendations are discussed. The main directions of the work of a clinical pharmacologist and discipline in general for coronavirus infection are given.
Clinical pharmacology, medicines, research, COVID-19.